IPNews® – In a San Francisco federal court on Wednesday, Complete Genomics argued that it is not infringing Illumina’s patents that cover technology related to DNA-sequencing kits.

Illumina filed a lawsuit against Complete Genomics in 2010 for allegedly using Illumina’s patented gene probe technology in its testing kits without authorization.  Complete Genomics asked U.S. District Judge Elizabeth LaPorte to grant its motion for summary judgment, arguing that it had provided sufficient evidence to prove that the probes it uses do not infringe.

To continue reading, click: Complete Genomics Claims It Did Not Infringe DNA-Sequencing Kit Patents